#weightregain — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #weightregain, aggregated by home.social.
-
https://www.europesays.com/uk/975336/ Weight lost with GLP-1 drugs still subject to rebound after stopping treatment – Baltimore Sun #AkkermansiaMuciniphila #DiabetesMedication #EliLilly #GLP1Drugs #Health #JohnsHopkins #Medication #NatureMedicine #ObesityResearch #orforglipron #UK #UnitedKingdom #Wegovy #WeightLossDrugs #WeightRegain #Zepbound
-
Weight loss jab users warned they could be ‘worse off than before’
Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #GLP-1 #GLP-1receptoragonists #Health #Mounjaro #wegovy #weightloss #Weightlossinjections #weightregain
https://www.newsbeep.com/us/505051/ -
Weight loss jab users warned they could be ‘worse off than before’
Wegovy and Mounjaro are approved by the NHS for weight loss use (Image: OMaltseva via Getty Images) People…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #GLP-1 #GLP-1receptoragonists #Health #Mounjaro #wegovy #weightloss #Weightlossinjections #weightregain
https://www.newsbeep.com/us/505051/ -
https://www.europesays.com/uk/805353/ Weight loss jab users warned they could be ‘worse off than before’ #GLP1 #GLP1ReceptorAgonists #Health #Medication #Mounjaro #UK #UnitedKingdom #Wegovy #WeightLoss #WeightLossInjections #WeightRegain
-
https://www.europesays.com/ie/368954/ Weight loss jab users warned they could be ‘worse off than before’ #Éire #GLP1 #GLP1ReceptorAgonists #Health #IE #Ireland #Medication #Mounjaro #Wegovy #WeightLoss #WeightLossInjections #WeightRegain
-
Skye Bioscience Shows 18.1% vs 49.8% Weight Regain in Phase 2
Skye Bioscience (Nasdaq: SKYE) will present a late-breaking oral abstract…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #-11.26cm #-13.2%vs-10.25% #18.1%vs49.8% #Atlanta #CBeyond #Headlines #late-breakingoral #nimacimab #Obesity #ObesityWeek2025 #Phase2 #Semaglutide #SKYE #SkyeBioscience #Topstories #TopStories #waistcircumference #weightregain
https://www.newsbeep.com/us/273093/ -
Skye Bioscience Shows 18.1% vs 49.8% Weight Regain in Phase 2
Skye Bioscience (Nasdaq: SKYE) will present a late-breaking oral abstract…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #BreakingNews #-11.26cm #-13.2%vs-10.25% #18.1%vs49.8% #Atlanta #CBeyond #Headlines #late-breakingoral #nimacimab #Obesity #ObesityWeek2025 #Phase2 #Semaglutide #SKYE #SkyeBioscience #Topstories #TopStories #waistcircumference #weightregain
https://www.newsbeep.com/us/273093/